Squarepoint Ops LLC Maravai Lifesciences Holdings, Inc. Transaction History

Squarepoint Ops LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.84 - $9.73 $1.94 Million - $2.76 Million	-283,631 Reduced 79.76%	71,959 $597,000
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $1.58 Million - $2.6 Million	229,421 Added 181.84%	355,590 $2.55 Million
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $939,478 - $1.61 Million	-183,851 Reduced 59.3%	126,169 $1.09 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $208,304 - $437,438	44,320 Added 16.68%	310,020 $2.03 Million
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $1.19 Million - $1.48 Million	98,399 Added 58.82%	265,700 $3.3 Million
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $1.55 Million - $1.97 Million	119,467 Added 249.75%	167,301 $2.34 Million
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $597,925 - $1.19 Million	47,834 New	47,834 $684,000
Q2 2022 Aug 15, 2022	SELL	$26.05 - $37.48 $532,149 - $765,641	-20,428 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$24.46 - $40.92 $996,133 - $1.67 Million	-40,725 Reduced 66.6%	20,428 $720,000
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $2.14 Million - $2.81 Million	61,153 New	61,153 $2.56 Million
Q3 2021 Nov 15, 2021	SELL	$36.8 - $60.62 $6.85 Million - $11.3 Million	-186,062 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $1.11 Million - $1.53 Million	34,062 Added 22.41%	186,062 $7.76 Million
Q1 2021 May 17, 2021	SELL	$25.8 - $38.49 $3.93 Million - $5.87 Million	-152,479 Reduced 50.08%	152,000 $5.42 Million
Q4 2020 Feb 16, 2021	BUY	$24.5 - $30.86 $7.46 Million - $9.4 Million	304,479 New	304,479 $8.54 Million

201

139M

250K

22.8K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $552M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.